Advertisement

Topics

FDA approves new drug Zelboraf for Erdheim-Chester disease

17:59 EST 6 Nov 2017 | News-Medical.net

The United States Food and Drugs Administration (FDA) has approved Zelboraf (vemurafenib), a drug for the treatment of adults with a are type of blood cancer called Erdheim-Chester Disease or ECD.

Original Article: FDA approves new drug Zelboraf for Erdheim-Chester disease

NEXT ARTICLE

More From BioPortfolio on "FDA approves new drug Zelboraf for Erdheim-Chester disease"

Quick Search
Advertisement
 

Relevant Topics

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...